DJ-1作为缓解心肌缺血-再输液损伤的新型治疗标
Jia-Bin Zhou1, Tian-Peng Wei1, Dan Wu1
1Department of Cardiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center Nanjing Medical University, Wuxi 214023, China.
Cardiovascular therapeutics
|January 1, 2025
概括
DJ-1蛋白在保护心脏免受 ischemia-reperfusion损伤方面表现有前途. 针对DJ-1的干预措施可能为缺血性心脏病提供新的治疗策略.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 缺血性心脏病 (IHD) 是全球死亡的主要原因.
- 缺血-再输液 (I/R) 损伤加剧了IHD,需要采取保护策略.
- DJ-1 (PARK7编码) 是一个关键蛋白质,参与细胞保护机制.
研究的目的:
- 审查DJ-1在心肌I/R损伤中的作用.
- 探索DJ-1作为IHD的治疗目标.
- 在心脏I / R的背景下总结DJ-1的保护功能.
主要方法:
- 对DJ-1和肌肉心脏I/R损伤的研究的文献综述.
- 对DJ-1已知的细胞功能 (自,线粒体完整性,亡,氧化应激) 的分析.
- 在心脏I / R模型中对基于DJ-1的干预措施的证据的审查.
主要成果:
- DJ-1表现出多方面的保护作用,防止细胞损伤.
- DJ-1的干预措施,包括外源的给药和药物激活,显示出心脏保护的潜力.
- DJ-1在细胞对氧化应激反应和在I/R期间维持线粒体功能方面发挥着至关重要的作用.
结论:
- DJ-1是缓解心肌缺血-再输液损伤的重要治疗标.
- 与DJ-1相关的策略对缺血性心脏病的新型治疗有前途.
- 对DJ-1的机制的进一步研究可以促进心血管治疗.
相关概念视频
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


